Biosynergy
From Wikipedia, the free encyclopedia
| BioSynergy Magazine | |
|---|---|
| Type | Semiannual Magazine |
| Format | Online and Print |
|
|
|
| Owner | BioSynergy Magazine Inc. |
| Editor | Justin Chakma |
| Staff Writers | 100 |
| Founded | September, 2007 |
| Headquarters | Toronto, Canada |
| Circulation | ~40,000 |
|
|
|
| Website: BioSynergyOnline.com | |
BioSynergy Magazine is a biannually published biotechnology magazine and self-titled non-profit corporation targeted at executives and scientists at the BIO International Convention.[1] It is the first magazine of its kind, and the only student-run biotechnology magazine in the world. Created in collaboration between students at the Massachusetts Institute of Technology, Stanford University and the University of Toronto in 2007, BioSynergy aims to catalyze the birth of biotech's next pioneers by conveying its compelling story. The magazine hopes to kindle and rekindle passion for biotechnology by focusing on its core ideas of entrepreneurship, risk-taking and long-term vision. It is supported by the Biotechnology Industry Organization, which represents 1300 biotechnology companies worldwide, and Nature Biotechnology, the leading academic journal as measured by impact factor in the area.
[edit] History
BioSynergy Magazine was founded by two students at the University of Toronto who strongly felt that research should have a purpose and relevance to society - that ivory towers have an obligation to translate basic research and serve society.[2] Given the lack of role models at the University of Toronto, they hoped to encourage more students in the life sciences to consider careers aside from traditional medicine. The magazine has since expanded to ten partner biotechnology campuses that gather and collect editorial content.
The first issue (The Biotech Odyssey) was launched in September 2007 at the University of Toronto and emphasized the linkages between entrepreneurial scientists, investors and clinicians that makes biotechnology possible.
The second issue (Our Biological Renaissance) launched at BIO2008 in San Diego emphasized the emergence of biology as a quantitative discipline as reflected in the increasing participation of physical scientists and engineers.
[edit] Content
The magazine welcomes guest contributions and story pitches from biotech professionals who have perspectives to share from their own entrepreneurial journey. Notable Contributors include:
- James Watson (1962 Nobel Prize Winner and co-discoverer of the double helix)
- Phillip Sharp (1992 Nobel Prize Winner)
- William Brody (President of Johns Hopkins University).
- Daniella Vasella (CEO of Novartis)
- Andrew Marshall (Editor in Chief of Nature Biotechnology)
- Hugh Grant (CEO of Monsanto)
[edit] Praise
"A most enjoyable read!" - Tom Perkins, Lead Investor and Co-Founder of KPCB
"I am very impressed." - Art Levinson, CEO of Genentech
"A tour de force." - The Scientist
